Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia

Journal of Clinical Virology

Volumn 54, Issue 1, 2012, Pages 61-65

  Andersson, Elin ^a   Kärrberg, Cecilia ^a   Rådberg, Thomas ^a   Blomqvist, Lennart ^b   Zetterqvist, Britt Marie ^c   Ryd, Walter ^a   Lindh, Magnus ^a   Horal, Peter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Section of Hematology   (Sweden)

^c NU Hospital Organisation   (Sweden)

Author keywords

Cervical neoplasia; E6 E7 mRNA; Genotyping; Papillomavirus; Real time PCR

Indexed keywords

PROTEIN E6; PROTEIN E7; VIRUS DNA;

ARTICLE; CANCER SCREENING; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; WART VIRUS;

COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS;

EID: 84861876103     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.01.012     Document Type: Article

References (30)

1. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24. S3/1-10.
2. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121:621-632.
3. IARC monograph working group on the evaluation of carcinogenic risks to humans. Human papillomaviruses, update 2009, vol. 100B. IARC Press, Lyon, p. 261-319.
4. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens. Part B: biological agents. Lancet Oncol 2009, 10:321-322.
5. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128:927-935.
6. de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048-1056.
7. Kjaer S.K., Frederiksen K., Munk C., Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010, 102:1478-1488.
8. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodriguez A.C., Quint W., Schiffman M., et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203:910-920.
9. Vaccarella S., Franceschi S., Snijders P.J., Herrero R., Meijer C.J., Plummer M. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010, 19:503-510.
10. Chaturvedi A.K., Myers L., Hammons A.F., Clark R.A., Dunlap K., Kissinger P.J., et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005, 14:2439-2445.
11. Spinillo A., Dal Bello B., Alberizzi P., Cesari S., Gardella B., Roccio M., et al. Clustering patterns of human papillomavirus genotypes in multiple infections. Virus Res 2009, 142:154-159.
12. Mejlhede N., Pedersen B.V., Frisch M., Fomsgaard A. Multiple human papilloma virus types in cervical infections: competition or synergy?. APMIS 2010, 118:346-352.
13. Spinillo A., Dal Bello B., Gardella B., Roccio M., Dacco M.D., Silini E.M. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009, 113:115-119.
14. Stoler M.H., Wright T.C., Sharma A., Apple R., Gutekunst K., Wright T.L. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 2011, 135:468-475.
15. Ghittoni R., Accardi R., Hasan U., Gheit T., Sylla B., Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010, 40:1-13.
16. McLaughlin-Drubin M.E., Munger K. Oncogenic activities of human papillomaviruses. Virus Res 2009, 143:195-208.
17. Pett M., Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J Pathol 2007, 212:356-367.
18. Sotlar K., Stubner A., Diemer D., Menton S., Menton M., Dietz K., et al. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 2004, 74:107-116.
19. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 2006, 11:2286-2302.
20. Lindh M., Gorander S., Andersson E., Horal P., Mattsby-Balzer I., Ryd W. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol 2007, 40:321-324.
21. Andersson E., Kärrberg C., Rådberg T., Blomqvist L., Zetterqvist B.M., Ryd W., et al. Type-specific HPV E6/E7 mRNA detection by real-time. PCR improves identification of cervical neoplasia. J Clin Microbiol 2011, 49:3794-3799.
22. Sjoeborg K.D., Trope A., Lie A.K., Jonassen C.M., Steinbakk M., Hansen M., et al. HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol 2010, 118:29-34.
23. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 2010, 70:3159-3169.
24. Bulkmans N.W., Bleeker M.C., Berkhof J., Voorhorst F.J., Snijders P.J., Meijer C.J. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 2005, 117:177-181.
25. Clifford G., Franceschi S. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer 2008, 122:1684-1685.
26. Molden T., Kraus I., Skomedal H., Nordstrøm T., Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 2007, 142:204-212.
27. Trope A., Sjoborg K., Eskild A., Cuschieri K., Eriksen T., Thoresen S., et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009, 47:2458-2464.
28. Ho C.M., Lee B.H., Chang S.F., Chien T.Y., Huang S.H., Yan C.C., et al. Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. Int J Cancer 2010, 127:622-632.
29. Cattani P., Zannoni G.F., Ricci C., D'Onghia S., Trivellizzi I.N., Di Franco A., et al. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 2009, 47:3895-3901.
30. Ciotti M., Paba P., Bonifacio D., Di Bonito L., Benedetto A., Favalli C. Single or multiple HPV types in cervical cancer and associated metastases. Oncol Rep 2006, 15:143-148.